The Diagnostic Accuracy of Second Trimester Plasma Glycated CD59 (pGCD59) to Identify Women with Gestational Diabetes Mellitus Based on the 75 g OGTT Using the WHO Criteria: A Prospective Study of Non-Diabetic Pregnant Women in Ireland

The aim of this study was to evaluate the ability of second trimester plasma glycated CD59 (pGCD59), a novel biomarker, to predict the results of the 2 h 75 g oral glucose tolerance test at 24–28 weeks of gestation, employing the 2013 World Health Organisation criteria. This was a prospective study...

Descripción completa

Detalles Bibliográficos
Autores principales: Bogdanet, Delia, Toth Castillo, Michelle, Doheny, Helen, Dervan, Louise, Luque-Fernandez, Miguel-Angel, Halperin, Jose A., O’Shea, Paula M., Dunne, Fidelma P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267743/
https://www.ncbi.nlm.nih.gov/pubmed/35807179
http://dx.doi.org/10.3390/jcm11133895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267743/
https://www.ncbi.nlm.nih.gov/pubmed/35807179
http://dx.doi.org/10.3390/jcm11133895

Ejemplares similares